Health Care & Life Sciences » Biotechnology | Cosmo Bio Co. Ltd.

Cosmo Bio Co. Ltd. | Income Statement

Fiscal year is January-December. All values JPY Millions.
2013
2014
2015
2016
2017
Sales/Revenue
7,050
7,235
7,357
7,427
7,068
Cost of Goods Sold (COGS) incl. D&A
4,429
4,811
4,976
4,655
4,535
Gross Income
2,621
2,424
2,381
2,772
2,533
SG&A Expense
2,350
2,262
2,181
2,257
2,339
EBIT
271
162
200
515
194
Unusual Expense
9
-
21
76
7
Non Operating Income/Expense
162
161
182
13
54
Pretax Income
451
330
407
456
400
Income Tax
137
130
158
179
149
Consolidated Net Income
314
200
249
276
250
Net Income
313
201
230
254
238
Net Income After Extraordinaries
313
201
230
254
238
Net Income Available to Common
313
201
230
254
237
EPS (Basic)
52.82
33.91
38.80
42.85
39.98
Basic Shares Outstanding
6
6
6
6
6
EPS (Diluted)
52.80
33.91
38.80
42.85
39.98
Diluted Shares Outstanding
6
6
6
6
6
EBITDA
367
248
279
600
350
Non-Operating Interest Income
9
7
4
3
2
Minority Interest Expense
1
1
19
22
12
Equity in Affiliates (Pretax)
-
-
-
-
143

About Cosmo Bio Co.

View Profile
Address
Toyo-Ekimae Building
Tokyo Tokyo 135
Japan
Employees -
Website http://www.cosmobio.co.jp
Updated 09/14/2018
Cosmo Bio Co., Ltd. engages in export, import, and sale of bio-research reagents, instruments and software, and clinical diagnostics. Its products include research reagents for immunology, gene engineering, tissue culture, and biochemistry. The company was founded on August 25, 1983 and is headquartered in Tokyo, Japan.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.